Matinas BioPharma Inc. (MTNB)
AMEX: MTNB
· Real-Time Price · USD
1.73
0.02 (1.17%)
At close: Oct 17, 2025, 3:59 PM
1.70
-1.65%
After-hours: Oct 17, 2025, 05:28 PM EDT
Matinas BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | 1.1M | 3.19M | 33.33K |
Cost of Revenue | 972K | 14.49M | 16.68M | 781.49K |
Gross Profit | -972K | -13.39M | -13.49M | -748.16K |
Operating Income | -20.16M | -23.77M | -24.59M | -24.73M |
Interest Income | n/a | n/a | n/a | 3K |
Pretax Income | -24.25M | -22.94M | -21M | -23.28M |
Net Income | -24.25M | -22.94M | -13.02M | -21.17M |
Selling & General & Admin | 8.73M | 10.37M | 11.1M | 10.18M |
Research & Development | 11.43M | 14.49M | 16.68M | 14.58M |
Other Expenses | -972K | n/a | -16.68M | 122.87K |
Operating Expenses | 19.19M | 24.86M | 11.1M | 24.77M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 24.59M | 24.86M | 27.78M | 24.77M |
Income Tax Expense | -80K | n/a | -7.98M | -2.11M |
Shares Outstanding (Basic) | 4.87M | 4.35M | 4.34M | 4.2M |
Shares Outstanding (Diluted) | 4.87M | 4.35M | 4.34M | 4.2M |
EPS (Basic) | -4.98 | -5.28 | -3 | -5.04 |
EPS (Diluted) | -4.98 | -5.28 | -3 | -5.04 |
EBITDA | -23.36M | -22.82M | -24.23M | -24.45M |
EBIT | -24.33M | -23.77M | -24.59M | -24.73M |
Depreciation & Amortization | 972K | 941K | 898K | 781.49K |
Source: Financial Modeling Prep. Financial Sources.